Prediction of Response to Temozolomide in Low‐Grade Glioma Patients Based on Tumor Size Dynamics and Genetic Characteristics

Both molecular profiling of tumors and longitudinal tumor size data modeling are relevant strategies to predict cancer patients' response to treatment. Herein we propose a model of tumor growth inhibition integrating a tumor's genetic characteristics (p53 mutation and 1p/19q codeletion) th...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:CPT Pharmacometrics Syst Pharmacol
Hlavní autoři: Mazzocco, P, Barthélémy, C, Kaloshi, G, Lavielle, M, Ricard, D, Idbaih, A, Psimaras, D, Renard, M‐A, Alentorn, A, Honnorat, J, Delattre, J‐Y, Ducray, F, Ribba, B
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2015
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4759703/
https://ncbi.nlm.nih.gov/pubmed/26904387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/psp4.54
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky